Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Consolidated Organic Net Sales Growth YoY by Quarter
Consolidated Organic Net Sales Growth YoY (%) (%)
Stryker Consolidated Organic Net Sales Growth YoY: 7.7% in Q3 2026, down 1.8 pts from a year earlier.
Latest, Q3 2026
7.7%
Period ended Sep 30, 2026
Change on a year earlier
-1.8 pts
9.5% in Q3 2025
History
26 quarters
Since Q1 2019
Sources
26
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Supplemental Sales Growth Analysis & Form 10-K/10-Q MD&A.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up consolidated Organic Net Sales Growth YoY
- Consolidated Unit Volume & Product Mix Growth YoY (%)7.6% · Q3 2026
- Consolidated Selling Price Impact on Net Sales Growth YoY (Annual, %)–
- Consolidated Constant Currency Net Sales Growth YoY (%)7.7% · Q3 2026
- Consolidated Acquisitions & Divestitures Net Impact YoY (%)0.0% · Q3 2026
- Consolidated Foreign Currency Exchange Impact YoY (%)0.0% · Q3 2026
- Consolidated Reported Net Sales Growth YoY (%)7.7% · Q3 2026
Cite this data
StockData. (2026). Stryker Consolidated Organic Net Sales Growth YoY (%), quarterly Q1 2019–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-cons-org
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.